Liraglutide: what it is and how it works
Liraglutide is a GLP-1 medicine used for type 2 diabetes and chronic weight management. Learn safety risks and what to expect.
Key facts
- Semaglutide + B12 is $157/month (billed $157 every 4 weeks), charged only after a clinician approves it.
- Answer a few health questions online. A licensed clinician reviews them. If approved, it ships to your door.
- Adults 18 or older. A licensed clinician reviews your health history and decides whether treatment is appropriate for you. Availability depends on the state you live in.
- A $20 clinician review, refunded if you don’t qualify.
Liraglutide is a prescription medicine in the GLP-1 receptor agonist class. FDA-approved liraglutide products are used for type 2 diabetes and for chronic weight management in specific adults and some adolescents, alongside diet and physical activity. This page explains what liraglutide is, what to expect, key safety warnings, and how access typically works. If you are exploring options through Vitals Vault, a licensed clinician reviews your health history and decides whether it is a fit.
- Liraglutide is a GLP-1 medicine that helps lower blood sugar and can support weight management.
- Compounded liraglutide is not FDA-approved and is made for an individual prescription.
- Common side effects are nausea, vomiting, diarrhea, constipation, and decreased appetite.
- Serious risks include thyroid C-cell tumors, pancreatitis, gallbladder disease, kidney problems, and low blood sugar with certain medicines.
- A clinician should review your history, other medications, and monitoring needs before you use it.
What liraglutide is
A GLP-1 prescription medicine
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 medicines mimic a natural gut hormone involved in appetite and blood sugar regulation. FDA-approved liraglutide is available as an injection for type 2 diabetes and for chronic weight management in specific people.
Different approved uses by product
FDA-approved liraglutide is marketed under different brand names with different indications. One product is indicated to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes, and to reduce major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease. Another product is indicated for chronic weight management in certain adults and adolescents, used with a reduced-calorie diet and increased physical activity.
What compounded means
Compounded liraglutide is prepared by a licensed pharmacy for an individual prescription and is not FDA-approved. That matters because compounded products do not go through the FDA approval process for safety, effectiveness, or manufacturing consistency. Your prescribing clinician and dispensing pharmacy should explain what you are receiving and how it is supplied.
- Drug class
- GLP-1 receptor agonist (incretin mimetic)
- FDA-approved indications
- Type 2 diabetes; chronic weight management (product-specific)
- Route
- Subcutaneous injection (FDA-approved products)
How liraglutide works
Helps with blood sugar
Liraglutide activates GLP-1 receptors, which increases glucose-dependent insulin secretion and decreases glucagon secretion. In plain terms, it helps your body release more insulin when blood sugar is high and reduces signals that raise blood sugar. This is why it is used for type 2 diabetes management.
Slows stomach emptying
GLP-1 medicines can slow gastric emptying, meaning food leaves your stomach more slowly. This can reduce post-meal blood sugar spikes for some people. It can also contribute to gastrointestinal side effects such as nausea, especially when starting or increasing dose.
Affects appetite signals
Liraglutide acts on appetite and satiety pathways in the brain. Many people notice reduced hunger or earlier fullness, which can support adherence to a reduced-calorie eating plan. Response varies, and safety and tolerability often determine whether it is a good option.
Who liraglutide may be for
Type 2 diabetes
FDA-approved liraglutide is used to improve blood sugar control in adults and in pediatric patients aged 10 years and older with type 2 diabetes. It is used along with diet and exercise, and sometimes alongside other diabetes medicines. It is not indicated for type 1 diabetes.
Chronic weight management
An FDA-approved liraglutide product is indicated for chronic weight management in adults with obesity or overweight with at least one weight-related condition, and in certain adolescents with obesity. It is intended to be used with a reduced-calorie diet and increased physical activity. Eligibility depends on age, BMI criteria, and medical history as described in the prescribing information.
People needing CV risk reduction
For some adults with type 2 diabetes and established cardiovascular disease, an FDA-approved liraglutide product is indicated to reduce the risk of major adverse cardiovascular events. This is a specific labeled indication and does not apply to everyone with diabetes. Your clinician can help determine whether you meet the criteria.
People who can use injections
FDA-approved liraglutide products are administered by subcutaneous injection. If you are not comfortable with injections, have barriers to consistent use, or have had severe reactions to similar medicines, that can affect whether liraglutide is a practical choice.
Who should not take liraglutide
MTC or MEN 2 history
FDA-approved liraglutide carries a boxed warning about thyroid C-cell tumors observed in rodents. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or in people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your clinician about any thyroid cancer history in you or close relatives.
Prior serious hypersensitivity
Do not use liraglutide if you have had a serious hypersensitivity reaction to liraglutide or any of its components. Seek urgent care for symptoms such as swelling of the face, lips, tongue, or throat, trouble breathing, or widespread rash.
Pregnancy considerations
For chronic weight management, liraglutide is not recommended during pregnancy because weight loss offers no benefit and may cause fetal harm. If you could become pregnant, discuss pregnancy plans and contraception with your clinician before starting. For diabetes management in pregnancy, your clinician will choose therapy based on your situation and available evidence.
Certain GI conditions
GLP-1 medicines can cause gastrointestinal side effects and slow gastric emptying. If you have severe gastrointestinal disease or a history of severe stomach emptying problems, discuss this before using liraglutide. Your clinician may recommend a different approach or closer monitoring.
History of pancreatitis
Acute pancreatitis has been reported with liraglutide. If you have a history of pancreatitis, your clinician may consider alternatives or discuss the uncertainty and monitoring plan. Seek urgent evaluation for severe abdominal pain that may radiate to the back, with or without vomiting.
What to expect with liraglutide
A gradual dose increase
Liraglutide is typically started at a lower dose and increased over time to improve tolerability, especially nausea and other stomach side effects. The exact titration schedule depends on the specific FDA-approved product and indication, or on the prescribing clinician's plan. Do not change your dose without clinician guidance.
Early appetite and GI changes
Many people notice decreased appetite or earlier fullness, along with nausea, constipation, or diarrhea during dose escalation. These effects often improve as your body adjusts, but some people cannot tolerate the medicine. Hydration and food choices can matter, and your clinician can help troubleshoot.
Monitoring and follow-up
If you use liraglutide for diabetes, your clinician may monitor blood sugar and adjust other diabetes medicines to reduce hypoglycemia risk. For weight management, follow-up focuses on side effects, adherence, and whether continuing makes sense for your goals and safety. Tell your clinician about symptoms that could suggest gallbladder problems, pancreatitis, or kidney issues.
Injection basics are label-based
FDA-approved liraglutide products are injected under the skin. The prescribing information and Instructions for Use describe approved injection sites and handling. Your clinician or pharmacist should show you how to use the pen safely; for compounded liraglutide, the prescribing clinician and dispensing pharmacy provide instructions.
Liraglutide side effects and warnings
Nausea
Nausea is one of the most common side effects with liraglutide and other GLP-1 medicines. It is often most noticeable when starting or increasing dose. Eating smaller meals and avoiding very fatty foods may help, but persistent or severe symptoms should be reviewed by a clinician.
Vomiting or diarrhea
Vomiting and diarrhea can occur and may lead to dehydration. Dehydration can increase the risk of kidney problems, especially if you already have kidney disease or take medicines that affect fluid balance. Contact a clinician if you cannot keep fluids down or symptoms are severe.
Constipation and stomach pain
Constipation, abdominal discomfort, and indigestion have been reported with liraglutide. These may improve over time, but ongoing pain should be evaluated to rule out gallbladder disease or pancreatitis. Tell your clinician if pain is severe, persistent, or associated with vomiting or fever.
Low blood sugar with other drugs
Liraglutide alone has a lower risk of hypoglycemia, but the risk increases when used with insulin or insulin secretagogues such as sulfonylureas. Your clinician may adjust other diabetes medicines and advise how to monitor. Seek help urgently for severe hypoglycemia symptoms such as confusion or loss of consciousness.
Pancreatitis
Acute pancreatitis has been reported in people taking liraglutide. Stop using the medication and seek urgent evaluation for severe abdominal pain that may radiate to the back, with or without vomiting, as described in the prescribing information. If pancreatitis is confirmed, liraglutide should not be restarted.
Thyroid C-cell tumor warning
FDA-approved liraglutide products carry a boxed warning about thyroid C-cell tumors seen in rodents; it is unknown whether this risk applies to humans. Do not use liraglutide if you have a personal or family history of medullary thyroid carcinoma or MEN 2. Report a neck lump, hoarseness, trouble swallowing, or shortness of breath to a clinician.
Gallbladder disease
Gallbladder problems, including gallstones and cholecystitis, have been reported with GLP-1 medicines including liraglutide. Seek medical evaluation for right upper abdominal pain, fever, yellowing of the skin or eyes, or persistent nausea and vomiting. Your clinician may order imaging or labs if symptoms suggest gallbladder disease.
Kidney problems
Acute kidney injury and worsening chronic kidney disease have been reported, sometimes in the setting of nausea, vomiting, diarrhea, or dehydration. If you have kidney disease, your clinician may monitor more closely and counsel you on hydration. Get medical help if you have reduced urination, swelling, or severe weakness.
Allergic reactions
Serious hypersensitivity reactions including anaphylaxis and angioedema have been reported. Seek emergency care for swelling of the face, lips, tongue, or throat; trouble breathing; or widespread rash. Do not use liraglutide again if you have had a serious reaction.
Heart rate increase
In clinical studies, liraglutide was associated with increases in resting heart rate. Tell your clinician if you have palpitations, a racing heartbeat, or dizziness. People with certain heart rhythm conditions may need closer monitoring.
Cost and access for liraglutide
What drives cost
Your out-of-pocket cost depends on whether you are using an FDA-approved brand product or a compounded formulation, the dose and duration prescribed, and whether you have insurance coverage for the specific indication. Pharmacy network rules, prior authorization, and supply availability can also affect what you pay. Current prices for the Vitals Vault option are shown on this page in the price block.
Insurance coverage varies
Coverage is often different for diabetes indications versus chronic weight management. Some plans cover GLP-1 medicines for type 2 diabetes but exclude weight-loss medications, or require documentation of BMI and prior attempts at lifestyle changes. A clinician can help document medical necessity when appropriate, but approval is not guaranteed.
Compounded access considerations
Compounded liraglutide is prepared by a licensed pharmacy for an individual prescription and is not FDA-approved. Access may depend on whether a clinician determines it is appropriate and whether a dispensing pharmacy can compound it under applicable standards. Ask what formulation you will receive and what follow-up is included.
How to get liraglutide safely
- 1
Complete an intake
Share your goals, medical history, current medications, and any prior GLP-1 side effects.
- 2
Review labs if needed
A clinician may ask for recent lab results before prescribing, especially for metabolic risk.
- 3
Clinician evaluation
A licensed clinician reviews your information and decides whether liraglutide is appropriate for you.
- 4
Start with follow-up support
If prescribed, follow the plan for check-ins, side effect management, and monitoring.
Frequently Asked Questions
What is liraglutide used for?
FDA-approved liraglutide is used for type 2 diabetes, and a specific liraglutide product is also approved for chronic weight management in certain adults and adolescents. The exact indication depends on the product and labeling. A clinician can help match the right option to your situation.
Is liraglutide the same as Ozempic?
No. Ozempic is semaglutide, while liraglutide is a different GLP-1 receptor agonist. They share some effects and risks, but they differ in dosing schedules, indications, and product labeling.
What are the most common liraglutide side effects?
The most common side effects are gastrointestinal, including nausea, vomiting, diarrhea, constipation, and decreased appetite. These are often most noticeable when starting or increasing dose. Tell a clinician if symptoms are severe or do not improve.
What serious warnings should I know about with liraglutide?
FDA-approved liraglutide has a boxed warning about thyroid C-cell tumors and should not be used with a personal or family history of MTC or MEN 2. Serious risks also include pancreatitis, gallbladder disease, kidney problems, severe allergic reactions, and hypoglycemia when combined with certain diabetes medicines. Seek urgent care for severe abdominal pain or allergic symptoms.
How much does liraglutide cost?
Cost depends on the product (FDA-approved brand versus compounded), the prescribed dose and duration, and whether insurance covers the indication. Pharmacy access and prior authorization can also affect out-of-pocket cost. If you are viewing the Vitals Vault option, current prices are shown on this page in the price block.